Target intelligence / Profile preview

HLA complex group 9 (non-protein coding) (HCG9)

Target
HCG9
Molecular classification
Other (Non-protein-coding RNA gene)
01

Overview

HLA complex group 9 (HCG9) is a member of the PERB11 gene family located in the major histocompatibility complex (MHC) region on chromosome 6p21.33.[1] Unlike classical HLA genes, HCG9 is a non-protein-coding RNA gene and does not encode a classical receptor, enzyme, or transporter. It can exist in several splice variants but is primarily of interest due to epigenetic (especially DNA methylation) variation associated with psychiatric conditions, such as bipolar disorder. Some epigenetic studies suggest that differences in DNA methylation of HCG9 in brain, blood, and germline samples may relate to the pathogenesis of major psychosis and other psychiatric diseases.[1] It is not a direct therapeutic or diagnostic target and does not code for a protein product. Summary logic: HLA complex group 9 is not a classical therapeutic target like a receptor or enzyme; rather, it is a non-coding locus best known for epigenetic variation. Care should be taken not to confuse it with protein-coding classical HLA molecules (e.g., HLA-A, HLA-B, HLA-C), which are critical immune system targets.[1]

Other names
PERB11HCGIXHCGIX-4HCGIX4HLA complex group 9 (non-protein coding)HCG9
02

Biological functions

Regulation of DNA methylationEpigenetic regulation
03

Disease associations

Other (Epigenetic differences associated with bipolar disorder and potentially other psychiatric conditions)[1]
04

Biomarkers

DNA methylation status at the HCG9 locus may serve as a biomarker for certain psychiatric disorders such as bipolar disorder[1]

Beyond the preview

Go deeper on HLA complex group 9 (non-protein coding) (HCG9).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HLA complex group 9 (non-protein coding) (HCG9).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call